ATC 코드 N02

ATC 코드 N02는 ATC 코드의 진통제로 작용하는 약물을 정리한 코드이다. ATC 코드 N 신경계의 하위그룹을 이룬다. 동물용 의약품을 위한 코드(ATCvet 코드)의 경우 인체의약품 코드 앞에 Q가 들어가게 된다. 예 : QN01. N02AA01 Morphine N02AA02 Opium N02AA03 Hydromorphone N02AA04 Nicomorphine N02AA05 Oxycodone N02AA08 Dihydrocodeine N02AA09 Diamorphine N02AA10 Papaveretum N02AA51 Morphine, combinations N02AA55 Oxycodone, combinations N02AA58 Dihydrocodeine, combinations N02AA59 Codeine, combinations excluding psycholeptics N02AA79 Codeine, combinations with psycholeptics N02AB01 Ketobemidone N02AB02 Pethidine N02AB03 Fentanyl N02AB52 Pethidine, combinations excluding psycholeptics QN02AB53 Fentanyl, combinations excluding psycholeptics N02AB72 Pethidine, combinations with psycholeptics NO02AB60 Pethidine, mixed QN02AB73 Fentanyl, combinations with psycholeptics N02AC01 Dextromoramide N02AC03 Piritramide N02AC04 Dextropropoxyphene N02AC05 Bezitramide N02AC52 Methadone, combinations excluding psycholeptics N02AC54 Dextropropoxyphene, combinations excluding psycholeptics N02AC74 Dextropropoxyphene, combinations with psycholeptics N02AD01 Pentazocine N02AD02 Phenazocine N02AE01 Buprenorphine QN02AE90 Etorphine QN02AE99 Oripavine derivatives, combinations N02AF01 Butorphanol N02AF02 Nalbuphine N02AG01 Morphine and antispasmodics N02AG02 Ketobemidone and antispasmodics N02AG03 Pethidine and antispasmodics N02AG04 Hydromorphone and antispasmodics N02AX01 Tilidine N02AX02 Tramadol N02AX03 Dezocine N02AX05 Meptazinol N02AX06 Tapentadol N02AX52 Tramadol, combinations N02BA01 Acetylsalicylic acid N02BA02 Aloxiprin N02BA03 Choline salicylate N02BA04 Sodium salicylate N02BA05 Salicylamide N02BA06 Salsalate N02BA07 Ethenzamide N02BA08 Morpholine salicylate N02BA09 Dipyrocetyl N02BA10 Benorilate N02BA11 Diflunisal N02BA12 Potassium salicylate N02BA14 Guacetisal N02BA15 Carbasalate calcium N02BA16 Imidazole salicylate N02BA51 Acetylsalicylic acid, combinations excluding psycholeptics N02BA55 Salicylamide, combinations excluding psycholeptics N02BA57 Ethenzamide, combinations excluding psycholeptics N02BA59 Dipyrocetyl, combinations excluding psycholeptics N02BA65 Carbasalate calcium combinations excluding psycholeptics N02BA71 Acetylsalicylic acid, combinations with psycholeptics N02BA75 Salicylamide, combinations with psycholeptics N02BA77 Ethenzamide, combinations with psycholeptics N02BA79 Dipyrocetyl, combinations with psycholeptics N02BB01 Phenazone N02BB02 Metamizole N02BB03 Aminophenazone N02BB04 Propyphenazone N02BB05 Nifenazone N02BB51 Phenazone, combinations excluding psycholeptics N02BB52 Metamizole sodium, combinations excluding psycholeptics N02BB53 Aminophenazone, combinations excluding psycholeptics N02BB54 Propyphenazone, combinations excluding psycholeptics N02BB71 Phenazone, combinations with psycholeptics N02BB72 Metamizole sodium, combinations with psycholeptics N02BB73 Aminophenazone, combinations with psycholeptics N02BB74 Propyphenazone, combinations with psycholeptics N02BE01 Paracetamol N02BE03 Phenacetin N02BE04 Bucetin N02BE05 Propacetamol N02BE51 Paracetamol, combinations excluding psycholeptics N02BE53 Phenacetin, combinations excluding psycholeptics N02BE54 Bucetin, combinations excluding psycholeptics N02BE71 Paracetamol, combinations with psycholeptics N02BE73 Phenacetin, combinations with psycholeptics N02BE74 Bucetin, combinations with psycholeptics N02BG02 Rimazolium N02BG03 Glafenine N02BG04 Floctafenine N02BG05 Viminol N02BG06 Nefopam N02BG07 Flupirtine N02BG08 Ziconotide N02BG09 Menthol N02BG10 Nabiximols N02CA01 Dihydroergotamine N02CA02 Ergotamine N02CA04 Methysergide N02CA07 Lisuride N02CA51 Dihydroergotamine, combinations N02CA52 Ergotamine, combinations excluding psycholeptics N02CA72 Ergotamine, combinations with psycholeptics N02CB01 Flumedroxone N02CC01 Sumatriptan N02CC02 Naratriptan N02CC03 Zolmitriptan N02CC04 Rizatriptan N02CC05 Almotriptan N02CC06 Eletriptan N02CC07 Frovatriptan N02CX01 Pizotifen N02CX02 Clonidine N02CX03 Iprazochrome N02CX05 Dimetotiazine N02CX06 Oxetorone “ATC Index”. WHO Collaborating Centre for Drug Statistics Methodology.  “ATCvet Index”. WHO Collaborating Centre for Drug Statistics Methodology.